David Fredrickson
Vermögen: 41 666 $ am 31.05.2026
Vermögen: 41 666 $ am 31.05.2026
Mr. David Fredrickson is an Independent Director at Caris Life Sciences, Inc. and an Executive Vice President-Oncology Business Unit at AstraZeneca PLC.
He is on the Board of Directors at Caris Life Sciences, Inc. Mr. Fredrickson was previously employed as a President by AstraZeneca KK, a Vice President-Specialty Care by AstraZeneca LP, a Vice Chairman by European Federation of Pharmaceutical Industries & Assns, and a Manager-Business Unit by Genentech, Inc. He also served on the board at Japan Pharmaceutical Manufacturers Association.
He received his undergraduate degree from Georgetown University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 2.492 ( 0 % ) | 41 666 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.10.2017 |
| CARIS LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 01.08.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Japan Pharmaceutical Manufacturers Association | Direktor/Vorstandsmitglied | - |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Corporate Officer/Principal | - |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Direktor/Vorstandsmitglied | - |
AstraZeneca KK
AstraZeneca KK Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells medical drugs | Präsident | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
AstraZeneca KK
AstraZeneca KK Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells medical drugs | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Caris Life Sciences, LLC
Caris Life Sciences, LLC BiotechnologyHealth Technology Operates as an AI-powered biotech company that provides molecular profiling services to develop oncology pharmaceuticals with proprietary platform | Health Technology |
Japan Pharmaceutical Manufacturers Association |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen